Colorectal cancer, traditionally viewed as an adult disease, is appearing more frequently in children and adolescents. Researchers who examined 84 patients aged 21 or younger reported a five‑fold increase in cases among 10‑ to 14‑year‑olds over the past two decades, more than a three‑fold rise among 15‑ to 19‑year‑olds, and nearly a doubling in the 20‑ to 24‑year‑old group.
Rapid increase and aggressive disease
The median age of the cohort was just 16.5 years, and 80 % had no known family history of colorectal cancer. By the time of diagnosis, more than half of the patients were already at Stage 3, indicating local spread, while 29 % were at Stage 4, meaning distant metastasis. The study noted that cancers diagnosed in people 21 and younger are more likely to be advanced, with nearly half of the patients (45.2 % or 38 individuals) dying from the disease by the end of the observation period. Recurrence was also common, affecting 36.9 % of the group, and most of those recurrences progressed to late‑stage disease.
Symptoms often overlooked
Researchers attribute part of the poor outcome to delayed diagnosis. They argue that “low rates of this type of cancer in young people” lead clinicians to overlook warning signs that can mimic benign conditions such as hemorrhoids or irritable bowel syndrome. The study identified four symptoms most frequently reported before diagnosis: persistent back or abdominal pain that does not improve with rest or therapy; changes in bowel habits, including diarrhea, constipation, or narrow ribbon‑like stools; unexplained weight loss despite adequate intake; and rectal bleeding that may appear as bright red streaks, dark red blood, or black, tarry stools. The authors specifically urged providers to take unexplained weight loss and rectal bleeding seriously in younger patients.
Diagnostic pathway and treatment considerations
When a young patient presents with these signs, clinicians typically begin with a physical exam and a review of medical history, followed by stool and blood tests for screening. If results raise concern, imaging studies and a colonoscopy are performed, allowing for tissue sampling and definitive diagnosis. Treatment regimens reported in the study included surgery, chemotherapy, radiation therapy, and creation of an ostomy to divert waste. Despite aggressive multimodal therapy, the high rates of recurrence and mortality underscore the need for earlier detection.
Early identification dramatically improves prognosis. When colorectal cancer is caught at Stage 1 or Stage 2, five‑year survival rates approach 90 %. The investigators highlighted that as “early‑onset adult cancers are seen in younger and younger patients, the logistical considerations of adult and pediatric care teams and carefully tailored treatment regimens are paramount.” Researchers continue to explore why incidence is climbing among youth, pointing to a mix of obesity, Western dietary patterns rich in processed red meat and sugar, and environmental exposures such as microplastics, pesticides, antibiotics, and infections like E. coli.
The study’s findings call for heightened awareness among both healthcare professionals and families. Recognizing the four most common symptoms and pursuing prompt evaluation could shift more cases to earlier stages, where survival outcomes are markedly better.
Steve Lopez is a Senior Editorial Columnist and Health & Public Policy reporter for News Raise. Steve focuses on healthcare advancements, medical technologies, and public health policies.
